Research status of epilepsy biomarkers based on genomics and metabonomics
10.13699/j.cnki.1001-6821.2017.18.031
- VernacularTitle:基因组学与代谢组学技术在癫痫生物标志物中的研究现状
- Author:
Shi-Hao LIU
1
;
Ya-Nan CHEN
;
Shan-Sen XU
;
Li-Mei ZHAO
Author Information
1. 中国医科大学附属盛京医院药学部
- Keywords:
epilepsy;
biomarkers;
genomics;
metabonomics
- From:
The Chinese Journal of Clinical Pharmacology
2017;33(18):1843-1846
- CountryChina
- Language:Chinese
-
Abstract:
Epilepsy is a serious neurological disease,its pathogenesis is not yet clear,and diagnosis is lack of sensitive and reliable method.It is of great significance to find biomarkers with clinical value.The combination of genomics and metabolomics technology plays an important role in the screening of biomarkers,this article reviews the application of genomics and metabonomics in the study of epilepsy biomarkers,hoping to provide new ideas for screening epilepsy biomarkers.
